BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36573352)

  • 21. Preoperative chemoradiation therapy decreases the number of lymph nodes resected during esophagectomy.
    Issaka A; Ermerak NO; Bilgi Z; Kara VH; Celikel CA; Batirel HF
    World J Surg; 2015 Mar; 39(3):721-6. PubMed ID: 25344144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer.
    Blackham AU; H Naqvi SM; Schell MJ; Jin W; Gangi A; Almhanna K; Fontaine JP; Hoffe SE; Frakes J; Venkat P; Pimiento JM
    J Surg Oncol; 2018 Feb; 117(2):150-159. PubMed ID: 28833197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.
    Xu ZC; Su BA; Li JC; Cheng WF; Chen J
    Cancer Radiother; 2023 May; 27(3):189-195. PubMed ID: 36754752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the causes of failure after radical surgery in patients with
    Shen WB; Gao HM; Zhu SC; Li YM; Li SG; Xu JR
    World J Surg Oncol; 2017 Oct; 15(1):192. PubMed ID: 29070049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supracarinal lymph node positivity in esophageal squamous cell carcinoma (ESCC) and factors predicting metastasis in supracarinal compartment nodes: Should a total mediastinal node dissection be the standard of care?
    Jain AR; Sadhwani MA; Vyas RD; Pandya SJ; Sharma MR; Warikoo V; Puj KS; Salunke AA
    Indian J Cancer; 2023; 60(2):185-190. PubMed ID: 37530239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection.
    Park SY; Lee J; Jeon YJ; Cho JH; Kim HK; Choi YS; Zo JI; Shim YM
    Ann Surg Oncol; 2024 May; 31(5):3399-3408. PubMed ID: 38082171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nodal Yield <15 Is Associated With Reduced Survival in Esophagectomy and Is a Quality Metric.
    Bolger JC; Castro PP; Marwah A; Tavakoli I; Espin-Garcia O; Darling GE; Yeung JC
    Ann Thorac Surg; 2023 Jul; 116(1):130-136. PubMed ID: 36918078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
    Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
    BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic significance of lymphovascular invasion in patients with superficial esophageal squamous cell carcinoma reaching the muscularis mucosae or with slight invasion of the submucosa.
    Oguma J; Ishiyama K; Kurita D; Kanematsu K; Kubo K; Utsunomiya D; Abe S; Makiguchi M; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Saito Y; Daiko H
    Surgery; 2023 May; 173(5):1162-1168. PubMed ID: 36801078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection.
    Nakamura T; Ota M; Narumiya K; Sato T; Ohki T; Yamamoto M; Mitsuhashi N
    Ann Surg Oncol; 2008 Sep; 15(9):2451-7. PubMed ID: 18592318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
    Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
    Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Significance of the Pre-therapeutic Nodal Size in Patients Undergoing Neo-Adjuvant Treatment Followed by Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Mine S; Watanabe M; Imamura Y; Okamura A; Kurogochi T; Sano T
    World J Surg; 2017 Jan; 41(1):184-190. PubMed ID: 27468743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.
    Peyre CG; Hagen JA; DeMeester SR; Van Lanschot JJ; Hölscher A; Law S; Ruol A; Ancona E; Griffin SM; Altorki NK; Rice TW; Wong J; Lerut T; DeMeester TR
    Ann Surg; 2008 Dec; 248(6):979-85. PubMed ID: 19092342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Jiang D; Liu XB; Xing WQ; Chen PN; Feng SK; Yan S; Lerut T; Sun HB
    Dis Esophagus; 2023 Apr; 36(5):. PubMed ID: 36385581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.